v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Operating expenses:        
Research and development $ 6,945 $ 12,639 $ 17,482 $ 22,964
Selling, general and administrative 7,407 2,320 12,958 4,611
Total operating expenses 14,352 14,959 30,440 27,575
Loss from operations (14,352) (14,959) (30,440) (27,575)
Other income (expense):        
Other income (expense) 1,635 (18) 287 (73)
Interest income 2,463 251 3,251 252
Total other income (expense), net 4,098 233 3,538 179
Net loss (10,254) (14,726) (26,902) (27,396)
Other comprehensive loss:        
Unrealized loss on marketable securities (61) (14) (68) (14)
Comprehensive loss $ (10,315) $ (14,740) $ (26,970) $ (27,410)
Net loss per share attributable to common stockholders-basic $ (0.40) $ (7.53) $ (1.77) $ (14.02)
Net loss per share attributable to common stockholders-diluted $ (0.40) $ (7.53) $ (1.77) $ (14.02)
Weighted-average Class A common shares outstanding, basic (in shares) [1] 25,608,594 1,956,244 15,163,103 1,953,464
Weighted-average Class A common shares outstanding, diluted (in shares) [1] 25,608,594 1,956,244 15,163,103 1,953,464
[1] Retroactively recast for the reverse recapitalization as described in Note 3. See Note 2 for further information on weighted-average common shares outstanding.